The requested product is for the Sequencing Core. These reagents will be used in vaccine production for human clinical trials. This item is listed under the FDA approved processes and is not able to be changed. The Place of performance is 9000 Rockville Pike, Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-1933960) to Laura Grey at [email protected], by 5:00 pm eastern standard time 5:00 PM eastern standard time, October 14, 2018. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.